Search This Blog

Friday, October 27, 2023

'Adderall shortage causing long-term problems for students with no end in sight'

 Parents and students are stuck in a web of confusion and frustration amid an Adderall shortage that has lasted more than a year, with grades slipping and caretakers driving for hours to fill prescriptions.

While ADHD can present in many forms, it commonly hurts children’s ability to concentrate in class and focus on their assignments, with the long-term effects showing up in academic performance.

“Their grades are suffering, they’re falling behind academically and they’re losing some motivation,” said Parker Houston, a pediatric psychologist and owner of Central Ohio Pediatric Behavioral Health who has been working with students on coping strategies during the shortage. 

With little hope for relief in sight, professionals are urging better communication among doctors, parents and schools to create an environment that can best help students who are missing their medication.

A year-plus and counting

On Oct. 12, 2022, the Food and Drug Administration (FDA) officially declared a shortage of the ingredients needed to make mixed amphetamine salts, the drug most commonly known as Adderall.

The shortage was first brought on by a disruption at a manufacturing plant run by Teva Pharmaceuticals, the largest supplier of Adderall in the U.S. But with that disruption since resolved, the ongoing scarcity is now attributed to heightened demand outpacing what drugmakers can supply.

The problem has not gone unnoticed, with House Democrats recently issuing a letter to both the FDA and the Drug Enforcement Administration (DEA) expressing their “continued concern” over their constituents being left in “limbo” trying to access the medication.

According to Michael Ganio, director of pharmacy practice and quality for the American Society of Health-System Pharmacists (ASHP), a year-long shortage is not abnormal. While shortages linked to isolated disruptions in the supply chain can resolve quickly, scarcity stemming from raw material acquisition or manufacturers waiting for permission from regulators to ramp up production can last significantly longer.

A lack of transparency in the manufacturing process makes it difficult to tell where the root of the problem lies.

Easier access, increased demand

During the COVID-19 pandemic, the DEA enacted telehealth flexibilities that permitted people to obtain prescriptions for controlled substances without needing to go to in-person appointments. That enabled easier access, both for those who were already on drugs such as Adderall and those who were new to it, which may partly explain the increased demand.

The DEA has extended these flexibilities to last through the end of 2024.

The Centers for Disease Control and Prevention says around 6 million children have been diagnosed with ADHD. Many in both grades K-12 and college rely on Adderall as the principal drug to help with diagnoses such as ADHD, which can present itself in numerous ways. 

“There is not a single clinical profile that can be considered the typical manifestation of this condition. We all know that there is a multitude of symptoms and also a multitude of levels with which these symptoms can exhibit themselves,” said Stephanie Sarkis, a psychotherapist who specializes in ADHD, anxiety and narcissistic disorders. 

Some cases are more mild and can be managed with therapeutic techniques and other drugs, but in more severe cases, Adderall can mean the difference between a student staying in school or not. 

Trouble beyond the classroom

Outside of academics, a stimulant like Adderall plays a role in regulating mood and sleep, all crucial for young students.

Alternative treatments for ADHD are available, including drugs such as Ritalin, Vyvanse and Strattera. But several of those are also currently in shortage, and they aren’t a simple replacement for someone who is accustomed to something else.

Ganio noted that some drugs within the same class are interchangeable, but this is not exactly the case when it comes to treating ADHD.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.